HIV/STI Research

The Section of Infectious Diseases conducts cutting edge research in the area of HIV and STIs, ranging from basic science and translational research to international clinical research studies. Take a look at some of the exciting work our faculty are working on in the area of HIV/STI.

Deborah Anderson, PhD

Dr. Anderson studies the immune defense of the genital tract against sexually-transmitted pathogens. We are currently working with epithelial cell lines and HIV-1 infection models.


Sabrina Assoumou, MD, MPH

Dr. Assoumou’s research focuses on medical complications of substance use including HIV and Hepatitis C virus (HCV).

 

Archana Asundi, MD

Her individual research program focuses on investigating cardiometabolic comorbidities and weight gain/obesity among people living with HIV. She also engages in quality improvement and continuing medical education in the area of HIV and aging with several projects ongoing targeted around improvement of health-related quality of life among people aging with HIV.

Mari Lynn Drainoni, PhD

Dr. Drainoni’s areas of expertise include the conduct of implementation research, qualitative research methods and mixed method studies with a focus on integrating research into practice.

 

Rachel Epstein, MD, MScE

Dr. Epstein is a clinician-scientist working to utilize large data sets and decision modelling to inform policy and program design to improve care for individuals with Hepatitis C, HIV, and substance use, with a particular focus on pregnant women and youth.

 

Andrew Henderson, PhD

Dr. Henderson’s research focuses on cellular mechanisms that regulate HIV replication and transcription. Current projects include exploring how signaling influences HIV infection and latency, devising strategies for long-term repression of HIV provirus and characterizing the transcriptional status of HIV provirus in T cell and macrophage subsets.

Jai Marathe, MBBS

Dr. Marathe’s current research focuses on HIV transmission across reproductive mucosa and the potential for topical use of various plant-derived antibodies (plantibodies) in prevention of HIV infection.

Manish Sagar, MD

Dr. Sagar’s laboratory is primarily interested in human immunodeficiency virus type 1 (HIV-1) mucosal HIV-1 transmission and antibodies.